First Affiliated Hospital, Sun Yat-sen University
Clinical trials sponsored by First Affiliated Hospital, Sun Yat-sen University, explained in plain language.
-
New pain combo eases suffering in liver cancer procedure
Symptom relief CompletedThis study looked at whether a combination of two pain medicines (hydromorphone and flurbiprofen) given through a vein could better control pain in 129 people with intermediate-to-advanced liver cancer undergoing a procedure called TACE. The goal was to reduce pain during and aft…
Phase: PHASE4 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Symptom relief
Last updated Apr 29, 2026 15:02 UTC
-
AI tool boosts survival in tough liver cancer cases
Knowledge-focused CompletedThis study tested a computer model to help doctors decide which liver cancer patients with tumor clots in the bile duct would benefit most from surgery. Researchers looked at 151 patients and found that following the model's advice improved 5-year survival. The goal is to make su…
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC
-
AI reads scans to pick right therapy for liver cancer
Knowledge-focused CompletedThis study looked back at medical records and scans of 3,000 people with liver cancer that could not be removed by surgery. Researchers used artificial intelligence to find patterns in the scans that might show which patients would do better with one type of liver-directed therap…
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:03 UTC